Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
883.4 INR | +0.20% | +5.24% | +36.07% |
Apr. 09 | Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs | MT |
Jan. 30 | Transcript : Strides Pharma Science Limited, Q3 2024 Earnings Call, Jan 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+36.07% | 972M | |
+18.59% | 22.25B | |
+13.49% | 14.39B | |
+12.83% | 13.55B | |
+38.02% | 11.27B | |
-9.80% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.35% | 5.01B | |
-5.36% | 4.51B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Science : Swings to Loss in Fiscal Q1